Literature DB >> 26733174

Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers.

Yi-Wei Wang1, Mei-Ling Zhu1, Rui-Fen Wang2, Wen-Ji Xue1, Xue-Ru Zhu1, Li-Feng Wang3, Lei-Zhen Zheng4.   

Abstract

Predicting lymph node metastasis (LNM) accurately is very important to decide treatment strategies preoperatively. The aim of this study was to explore risk factors that predict the presence of LNM in early gastric cancer (EGC). A total of 230 patients with EGC who underwent curative gastrectomy with lymph adenectomy at Xinhua Hospital from January 2006 to July 2014 were retrospectively reviewed. We studied the relationship between clinicopathological factors, biological markers (p53, ki67, nm23, vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR), E-cadherin (E-cad), beta-catenin (b-catenin), glutathione S-transferase (GST), and topoisomerase II (Topo II)), and LNM of EGC patients by chi-square test and logistic regression analysis. Meta-analyses were further conducted to review the effects of the proteins (P53, ki67, E-cad, and b-catenin) on LNM in ECG patients. LNM was detected in 42 (18.3 %) of 230 patients. Incidences of LNM was distinct in different tumor size (p = 0.044), depth of submucosal invasion (p < 0.0001), and P53 overexpression (p = 0.004). Multivariate analysis further indentified that large tumor size (≥20 mm, odds ratio (OR) = 2.168, p = 0.041), submucosa (OR = 4.000, p = 0.0005), and P53 overexpression (OR = 3.010, p = 0.022) were independent risk factors of LNM in EGC patients. The meta-analysis revealed a significantly statistical association of P53, ki67, and b-catenin with an increased risk of LNM in EGC patients (P53, OR = 1.81, p = 0.017; ki67, OR = 2.53, p = 0.0003; b-catenin, OR = 0.53, p = 0.01). Tumor size (≥20 mm), the depth of invasion (submucosa), and P53 overexpression may be helpful predictors of LNM in EGC patients. Furthermore, the results of meta-analysis revealed that P53, ki67 overexpression, and abnormal expression of b-catenin may be associated with LNM in EGC. The results need further validation in single large studies.

Entities:  

Keywords:  Biological markers; Clinicopathologic factors; Early gastric cancer; Lymph node metastasis

Mesh:

Substances:

Year:  2016        PMID: 26733174     DOI: 10.1007/s13277-015-4721-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  59 in total

1.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

2.  Predictive value of cathepsin D and Ki-67 expression at the deepest penetration site for lymph node metastases in gastric cancer.

Authors:  H Goishi; S Tanaka; K Haruma; M Yoshihara; K Sumii; G Kajiyama; F Shimamoto
Journal:  Oncol Rep       Date:  2000 Jul-Aug       Impact factor: 3.906

3.  Loss of E-cadherin expression in early gastric cancer.

Authors:  P Blok; M E Craanen; W Dekker; G N Tytgat
Journal:  Histopathology       Date:  1999-05       Impact factor: 5.087

4.  Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.

Authors:  M Tanaka; Y Kitajima; G Edakuni; S Sato; K Miyazaki
Journal:  Br J Surg       Date:  2002-02       Impact factor: 6.939

5.  Lymph node metastasis and preoperative diagnosis of depth of invasion in early gastric cancer.

Authors:  Y Seto; S Shimoyama; J Kitayama; K Mafune; M Kaminishi; T Aikou; K Arai; K Ohta; A Nashimoto; I Honda; H Yamagishi; Y Yamamura
Journal:  Gastric Cancer       Date:  2001       Impact factor: 7.370

6.  Lymph node metastasis in early gastric cancer: a clinicopathological analysis.

Authors:  Chun-Ying Wu; Jung-Ta Chen; Gran-Hum Chen; Hong-Zen Yeh
Journal:  Hepatogastroenterology       Date:  2002 Sep-Oct

Review 7.  Predicting lymph node status in early gastric cancer.

Authors:  Robert Michael Kwee; Thomas Christian Kwee
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

8.  Early gastric cancer: follow-up after gastrectomy in 159 patients.

Authors:  S Guadagni; P I Reed; B J Johnston; G De Bernardinis; M Catarci; M Valenti; F di Orio; M Carboni
Journal:  Br J Surg       Date:  1993-03       Impact factor: 6.939

9.  Pilot research for the correlation between the expression pattern of E-cadherin-β-catenin complex and lymph node metastasis in early gastric cancer.

Authors:  Takako Yoshii; Yohei Miyagi; Yoshiyasu Nakamura; Osamu Kobayashi; Yoichi Kameda; Shinichi Ohkawa
Journal:  Tumori       Date:  2013 Mar-Apr

10.  Molecular organization of the uvomorulin-catenin complex.

Authors:  M Ozawa; R Kemler
Journal:  J Cell Biol       Date:  1992-02       Impact factor: 10.539

View more
  9 in total

1.  Predictive value of E-cadherin and EpCAM for detection of metastatic lymph node in early gastric cancer.

Authors:  Bang Wool Eom; Keun Won Ryu; Hong Man Yoon; Myeong-Cherl Kook
Journal:  Chin J Cancer Res       Date:  2020-10-31       Impact factor: 5.087

Review 2.  Meta-Analysis of the Relationship between NM23 Expression to Gastric Cancer Risk and Clinical Features.

Authors:  Min Fang; Yifeng Tao; Zhimin Liu; Hao Huang; Min Lao; Lingsha Huang; Bo Zhu
Journal:  Biomed Res Int       Date:  2017-03-16       Impact factor: 3.411

3.  The role of E-cadherin expression in the treatment of western undifferentiated early gastric cancer: Can a biological factor predict lymph node metastasis?

Authors:  Gaetano Piccolo; Antonio Zanghì; Maria Di Vita; Pietro Bisagni; Francesca Lecchi; Andrea Cavallaro; Francesco Cardì; Emanuele Lo Menzo; Alessandro Cappellani
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

Review 4.  Significance of Lymph Node Metastasis in the Treatment of Gastric Cancer and Current Challenges in Determining the Extent of Metastasis.

Authors:  Shinichi Kinami; Hitoshi Saito; Hiroyuki Takamura
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

5.  Development and validation of a predictive model combining clinical, radiomics, and deep transfer learning features for lymph node metastasis in early gastric cancer.

Authors:  Qingwen Zeng; Hong Li; Yanyan Zhu; Zongfeng Feng; Xufeng Shu; Ahao Wu; Lianghua Luo; Yi Cao; Yi Tu; Jianbo Xiong; Fuqing Zhou; Zhengrong Li
Journal:  Front Med (Lausanne)       Date:  2022-10-03

6.  Risk factors for lymph node metastasis in early gastric cancer patients: Report from Eastern Europe country- Lithuania.

Authors:  Rimantas Bausys; Augustinas Bausys; Indre Vysniauskaite; Kazimieras Maneikis; Dalius Klimas; Martynas Luksta; Kestutis Strupas; Eugenijus Stratilatovas
Journal:  BMC Surg       Date:  2017-11-23       Impact factor: 2.102

7.  A nomogram composed of clinicopathologic features and preoperative serum tumor markers to predict lymph node metastasis in early gastric cancer patients.

Authors:  Lin-Yong Zhao; Yuan Yin; Xue Li; Chen-Jing Zhu; Yi-Gao Wang; Xiao-Long Chen; Wei-Han Zhang; Xin-Zu Chen; Kun Yang; Kai Liu; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Oncotarget       Date:  2016-09-13

8.  Construction and external validation of a nomogram that predicts lymph node metastasis in early gastric cancer patients using preoperative parameters.

Authors:  Yinan Zhang; Yiqiang Liu; Ji Zhang; Xiaojiang Wu; Xin Ji; Tao Fu; Ziyu Li; Qi Wu; Zhaode Bu; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2018-12       Impact factor: 5.087

9.  Development and validation of a nomogram for preoperative prediction of lymph node metastasis in early gastric cancer.

Authors:  Xiao-Yi Yin; Tao Pang; Yu Liu; Hang-Tian Cui; Tian-Hang Luo; Zheng-Mao Lu; Xu-Chao Xue; Guo-En Fang
Journal:  World J Surg Oncol       Date:  2020-01-02       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.